However, statistically significant correlations were not observed between the CSF levels of IL-36β and the serum levels of IL-17 or TNF-α in GBS patients (r = 0.135, P = .393, Fig. 5e; r = 0.284, P = .068, Fig. 5f, respectively). Here, IL17A is linked to Guillain-Barre syndrome.